Conferences
| 2010 | Diabetes UK Annual Professional Conference, Liverpool (Oral) Challenges of Treating to Target - Experiences and views of patients and staff participating in the three-year 4-T trial J Lawton, N Jenkins, A Farmer, N Hallowell, RR Holman Diabetic Medicine (2010);27 Supp 1:21 [Abstract] |
| 2009 | Diabetes UK Annual Professional Conference, Glasgow (Poster) Addition of exenatide therapy to insulin treatment in individuals with type 2 diabetes Price HC, Holman RR, Levy JC, Ayyagari U. Diabetic Medicine (2009);26:Suppl 1:141 [Abstract] |
| Diabetes UK Annual Professional Conference, Glasgow (Poster) Addition of Exenatide therapy to oral blood glucose lowering treatment in individuals with Type 2 diabetes Ayyagari U, Holman RR, Levy JC, Price HC Diabetic Medicine (2009);26:Suppl 1:141 [Abstract] | |
| 69th Scientific Session of the American Diabetes Association, New Orleans (Poster) Unravelling the Dynamics of Insulin Dose and Changes in Weight and HbA1c Paul SK, Holman RR Diabetes (2009);58:Suppl 1: A163 [Abstract] | |
| 69th Scientific Session of the American Diabetes Association, New Orleans (Publication only) Rationale and Design of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) Bethel MA, Green J, Califf RM, Holman RR Diabetes (2009);59:Suppl 1:A555 [Abstract] | |
| 69th Scientific Session of the American Diabetes Association, New Orleans (Publication only) Physical Activity in Adults at High Risk of Cardiovascular Disease Price HC, Griffin SJ, Holman RR Diabetes (2009);58:Suppl 1:A587 [Abstract] | |
| 69th Scientific Session of the American Diabetes Association, New Orleans (Publication only) Prevalence of Undiagnosed Dysglycaemia in Adults at High Risk of Cardiovascular Disease Price HC, Griffin SJ, Holman RR Diabetes (2009);58:Suppl 1:A639 [Abstract] | |
| 69th Scientific Session of the American Diabetes Association, New Orleans (Poster) Differences in Insulin Treatment Satisfaction Following Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes Farmer AJ, Oke J, Stevens R, Holman RR Diabetes (2009);58:Suppl 1:A130 [Abstract] | |
| 69th Scientific Session of the American Diabetes Association, New Orleans (Publication only) Do Glycoalbumin Levels Preferentially Reflect Postprandial Glucose Excursions? Hartweg J, Paul SJ, Fisher K, Carter R, Klyne R, Holman RR Diabetes (2009);58:Suppl 1:A505 [Abstract] | |
| 2008 | The Diabetes UK Annual Professional Conference, Glasgow (Poster) The UKPDS Life Expectancy Calculator for Individuals with Type 2 diabetes Price HC, Kennedy I, Clarke PM, Gray AM and Holman RR. Diabetic Medicine (2008);25:suppl 1:63 [Abstract] |
| 68th Scientific Session of the American Diabetes Association, San Francisco (Poster) European physicians overestimate life expectancy and the likely impact of interventions in individuals with type 2 diabetes Price HC, Thorne KI, Dukát A and Kellett J Diabetes (2008);57:(Suppl 1):A181 [Abstract] | |
| 44th Annual Meeting of the European Association for the Study of Diabetes, Rome (Poster) Performance of the UKPDS Risk Engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC-Norfolk cohort Simmons RK, Coleman RL, Price HC, Holman RR, Khaw KT, Wareham NJ, Griffin SJ Diabetologia (2008);51:Suppl 1:S549 [Abstract] | |
| 44th Annual Meeting of the European Association for the Study of Diabetes, Rome (Poster) Characteristics of patients requiring planned modification to regimen allocation during the first year of the 4-T Trial: need for twice-daily basal insulin or addition of a second insulin formulation Levy JC, Farmer AJ, Thorne KI, Paul SK, Darbyshire JL, Davies MJ, Holman RR Diabetologia (2008); (Accepted) [Abstract] | |
| 68th Scientific Session of the American Diabetes Association, San Francisco (Oral) Continuous Glucose Monitoring Results from the Treating to Target in Type 2 Diabetes (4-T) Trial Davies MJ, Levy JC, Thorne KI, Paul SK, Darbyshire JL, Holman RR. Diabetes (2008);57:(Suppl 1):A12 [Abstract] | |
| International Biometric Conference, Dublin (Oral) A Generalized Autoregressive Conditional Heteroscedasticity Model (GARCH) to Analyze Continuous Blood Glucose Monitoring Data for Diabetic Patients Sanjoy PK, Holman RR International Biometric Society (2008);978-0-9821919-0-3 [Abstract] | |
| International Biometric Conference, Dublin (Oral) Statistical Analysis of 8-Point Self Measured Capillary Glucose Profiles in Type 2 Diabetic Patients to Compare the Efficacy of Three Different Insulin Regimens Paul SK, Thorne KI, Holman RR International Biometric Society (2008);978-0-9821919-0-3 [Abstract] | |
| 2007 | 2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral) Does metformin prevent cardiovascular events? Holman RR Diabetes & Vascular Disease Research (2007);4:Suppl 1:S26 [Abstract] |
| 2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral) Abdominal obesity, metabolic syndrome and global cardiometabolic risk Holman RR Diabetes & Vascular Disease Research (2007);4:Suppl 1:S37 [Abstract] | |
| 2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral) A new era in the secondary prevention of CVD in prediabetes - the Acarbose Cardiovascular Evaluation (ACE) trial Holman RR Diabetes & Vascular Disease Research (2007);4:Suppl 1:S40 [Abstract] | |
| 2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Oral) The expanding evidence base - what have we added to our understanding of diabetes disease modification? Holman RR Diabetes & Vascular Disease Research (2007);4:Suppl 1:S43-S44 [Abstract] | |
| 2nd International Congress on Prediabetes and the Metabolic Syndrome, Barcelona (Poster) Acarbose Cardiovascular Evaluation (ACE) Trial in prediabetic subjects Holman RR, Pan CY Diabetes & Vascular Disease Research (2007);4:Suppl 1:S128 [Abstract] | |
| 67th Scientific Session of the American Diabetes Association, Chicago (Poster) The Oxford Risk Engine: A Cardiovascular Risk Calculator for Individuals with or without Type 2 diabetes Coleman RL, Stevens RJ, Holman RR Diabetes (2007);56:Suppl 1:A170 [Abstract] | |
| The Diabetes UK Annual Professional Conference, Glasgow (Poster) Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine Coleman RL, Stevens RJ, Holman RR Diabetic Medicine (2007);24:Suppl 1:56 [Abstract] | |
| 67th Scientific Session of the American Diabetes Association, Chicago (Publication only) Life-expectancy in Individuals with Type 2 Diabetes: Implications for Annuities. Price HC, Cull CA, Clarke PM, Gray AM and Holman RR Diabetes (2007);56:Suppl 1:A596 [Abstract] | |
| The Diabetes UK Annual Professional Conference, Glasgow (Poster) Framingham Equations Underestimate Cardiovascular Risk Compared with the UKPDS Risk Engine in People with Type 2 Diabetes. Price HC, Cull CA, Coleman RL, Stevens RJ and Holman RR Diabetic Medicine (2007);24:suppl 1:55 [Abstract] | |
| 28th Annual Conference of the International Society for Clinical Biostatistics, Alexandroupolis (Oral) Modelling Continuous Glucose Monitoring Data: A Statistical Challenge Paul SK, Holman RR ISCB Abstracts (2007);117 [Abstract] | |
| 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster) Are measures of adiposity associated independently with incident cardiovascular disease in individuals with newly diagnosed type 2 diabetes? Coleman RL, Holman RR Diabetologia (2007);50:Suppl 1:S502 [Abstract] | |
| 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Oral) Increased incidence of fractures in women who received rosiglitazone in ADOPT (A Diabetes Outcome Progression Trial) Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group Diabetologia (2007); (Accepted) [Abstract] | |
| 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Oral) Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain Haffner SM, Kahn SE, Zinman B, Holman R, Viberti GF, Herman WH, Lachin JM, Kravitz BG, Heise MA Diabetologia (2007); (Accepted) [Abstract] | |
| 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Oral) The distribution of macular hard exudates is related to future visual acuity in subjects with type 2 diabetes Stratton IM, Scanlon PH, Holman RR, Stirling RJ, Lipinsk HL, Aldington SJ Diabetologia (2007); (Accepted) [Abstract] | |
| 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster) Prevalence of glucokinase (GCK) mutations in people with elevated fasting glucose levels: implications for clinical trials Gloyn AL, van de Bunt M, Stratton I, Tucker L, Lonie L, Ellard S, Holman RR Diabetologia (2007); (Accepted) [Abstract] | |
| 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster) Determinants of monotherapy failure in ADOPT (A Diabetes Outcome Progression Trial) Holman RR, Kahn SE, S. Haffner M, Zinman B, Viberti GF, Herman WH, Lachin JM, Kravitz BG, Heise MA Diabetologia (2007); (Accepted) [Abstract] | |
| 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam (Poster) ADOPT: The effectiveness of metformin versus glyburide in type 2 diabetes Herman WH, Haffner SM, Kahn SE, Zinman B, Holman RR, Viberti GF, Lachin JM, Kravitz BG, Heise MA Diabetologia (2007); (Accepted) [Abstract] | |
| 2006 | Diabetes UK, Birmingham (Poster) Estimating risk of clinically evident neuropathy in type 2 diabetes: a UKPDS risk equation Coleman RL, Stevens RJ, Holman RR Diabetic Medicine (2006); 23:Suppl. 2:51 |
| 66th Scientific Session of the American Diabetes Association, Washington DC (Oral) Estimating Risk of Clinically Evident Retinopathy in Type 2 Diabetes. Coleman RL, Stevens RJ, Aldington SJ, Holman RR Diabetes (2006);55:Suppl 1:A53 | |
| 27th Annual Conference of The International Society for Clinical Biostatistics, Geneva (Poster) Nonparametric regression techniques for inference in highly skewed quality of life data - a case study with LDS diabetes patients using sf-36 scores Paul SK, Holman RR ISCB2006 Abstract Book (2006);215 | |
| Diabetes UK , Birmingham (Poster) Treating to target in Type 2 diabetes (4-T) study of analogue insulin initiation and titration Farmer AJ, Thorne KA, Stratton IM, Davies M, Keenan J, Teo E, Levy J, Holman RR Diabetic Medicine (2006);23:Suppl 2:85 [Abstract] | |
| Diabetes UK, Birmingham (Poster) LDL cholesterol levels alone do not adequately assess coronary heart disease risk in Type 2 diabetes Farmer AJ, Paul S, Stratton IM, Tucker L, Neil HAW, Holman RR Diabetic Medicine (2006);23:Suppl 2:89 [Abstract] | |
| 66th Scientific Session of the American Diabetes Association, Washington DC (Publication only) LDL Cholesterol Level Alone does not Assess Coronary Heart Disease Risk Adequately in Type 2 Diabetes Farmer AJ, Paul SK, Stratton IM, Tucker L, Neil AW and Holman RR Diabetes (2006);55:Suppl 1:A462 [Abstract] | |
| 2005 | 41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Poster) Obesity is a major determinant of the association of C-reactive protein levels with the number of metabolic syndrome components in recently diagnosed, drug-naive type 2 diabetes: the ADOPT study cohort Kahn SE, Zinman B, Viberti G, Kravitz BG, Yu D, Heise MA, Freed MI, the ADOPT Study Group Diabetologia (2005);48:suppl 1:A249 [Abstract] |
| 41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Poster) BMI and ratio of triglycerides to HDL are most predictive of insulin resistance in a drug naive population with type 2 diabetes Patwardhan R, Lin X, Zambanini A, Eslava S, the ADOPT Study Group Diabetologia (2005);48:suppl 1:A222 [Abstract] | |
| 65th Scientific Sessions of the American Diabetes Association, San Diego (Poster) Hepatic enzymes are associated with insulin resistance and impaired fibrinolysis in drug naïve, recently diagnosed type 2 diabetes subjects Haffner SM, Kahn SE, Heise MA, O'Neill MC, Zinman B, the ADOPT Study Group Diabetes (2005);54:suppl 1:A255 [Abstract] | |
| 65th Scientific Sessions of the American Diabetes Association, San Diego (Poster) Obesity is a major determinant of the association of C-reactive protein levels with the number of metabolic syndrome components in type 2 diabetes Kahn SE, Zinman B, Viberti G, Kravitz BG, Yu D, Heise MA, Freed MI, the ADOPT Study Group Diabetes (2005);54:suppl 1:A255 [Abstract] | |
| 65th Scientific Sessions of the American Diabetes Association, San Diego (Poster) A Cardiovascular Risk Calculator for Type 2 Diabetes Coleman RL, Stevens RJ, Matthews DR, Holman RR Diabetes (2005);54:Suppl 1:A172 | |
| 41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Oral) Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation Coleman RL, Stevens RJ, Holman RR Diabetologia (2005);48:Suppl 1:A32 | |
| 41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Oral) FPG and HbA1c are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes Kim JI, Stevens RJ, Holman RR Diabetologia (2005);48:Suppl 1:A33 [Abstract] | |
| 41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Oral) Susceptibility for latent autoimmune diabetes in adults (LADA) is determined by variation at the IDDM2 (insulin-gene) locus in white Caucasian patients from UK repositories Desai M, Zeggini E, Owen KR, Holman RR, Levy JC, Hattersley AT, Hitman GA, Walker M, McCarthy MI, Clark A Diabetologia (2005);48:Suppl1:A86 [Abstract] | |
| 41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Oral) Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (LADA) in the UKPDS Clark A, Desai M, Cull CA, Horton VA, Christie MR, Bingley PJ, Bonifacio E, Levy JC, Holman RR Diabetologia (2005);48:Suppl 1:A86 [Abstract] | |
| 41st Annual Meeting of the European Association for the Study of Diabetes, Athens (Poster) Genotype and beta cell response to therapy in a large type 2 diabetic cohort Powell BL, Stratton IM, Holman RR, McCarthy MI Diabetologia (2005);48:Suppl 1:A101-A102 [Abstract] | |
| Diabetes UK Annual Professional Conference, Glas (Poster) AFORRD: a multi-centre trial evaluating potential cardiovascular risk reduction in patients with type 2 diabetes randomised in a factorial design to atorvastatin and/or omega-3 polyunsaturated fatty acids Farmer AJ,Neil HAW, Holman RR Diabetic Medicine (2005);22:S2:63 [Abstract] | |
| 2004 | 40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Oral) Evaluating SCORE and Framingham fatal coronary heart disease risk equations using UKPDS data Coleman RL, Stevens RJ, Holman RR Diabetologia (2004);47:Suppl 1:A42 |
| 40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Oral) Could non-HDL cholesterol replace total/HDL cholesterol ratio to estimate coronary heart disease risk in the UKPDS risk engine? Stevens RJ, Coleman RL, Shine BL, Holman RR Diabetologia (2004);47:Suppl 1:A61 [Abstract] | |
| 40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Oral) Risk factors for neuropathy in UKPDS Stratton IM, Holman RR, Boulton AJM Diabetologia (2004);47:Suppl 1:A47 [Abstract] | |
| 40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster) The haemoglobin glycation index is reproducible in dysglycaemic individual but is not explained by post-challenge plasma glucose levels Kim JI, Stevens RJ, Holman RR Diabetologia (2004);47:Suppl 1:A122 [Abstract] | |
| 40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster) GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requirement Desai M, Williams AJK, Horton VA, Bingley PJ, Levy JC, Cull CA, Holman RR, Bonifacio E, Christie MR, Clark A Diabetologia (2004);47:Suppl 1:A186 [Abstract] | |
| 40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Oral) Cost utility analysis of intensive blood-glucose control, tight blood pressure control and metformin in patients with Type 2 diabetes Clarke PM, Gray A, Stevens RJ, Holman RR Diabetologia (2004);47:Suppl 1:A50 [Abstract] | |
| 40th Annual Meeting of the European Association for the Study of Diabetes, Munich (Poster) A calculator for HOMA Holman RR, Hines G, Kennedy I, Stevens RJ, Matthews D, Levy JC Diabetologia (2004);47:Suppl 1:A222 [Abstract] | |
| 2003 | 16th International Diabetes Federation Congress, Paris (Oral) Estimations of the clinical benefit of optimal blood glucose, blood pressure and lipid control in type 2 diabetic patients with the metabolic syndrome Koro CE, Bowlin S, Sun Y, Gomez-Camineros A, the ADOPT Study Group Diabetologia (2003);46:Suppl 2:A76 [Abstract] |
| 16th International Diabetes Federation Congress, Paris (Poster) Differences in the prevalence of the metabolic syndrome between ethnic groups in recently diagnosed type 2 diabetes in the North American cohort of the ADOPT study Haffner SM, Zinman B, Kahn SE, Herman WH, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group Diabetologia (2003);46:suppl 2:A144 [Abstract] | |
| 16th International Diabetes Federation Congress, Paris (Poster) Symptoms and health status in a recently-diagnosed type 2 diabetic population: the ADOPT study Perry A, Herman W, Freed MI, Heise MA, Kravitz B, the ADOPT Study Group Diabetes Metabolism (2003);29:4S16-4S17 [Abstract] | |
| 16th International Diabetes Federation Congress, Paris (Poster) Are different clinical practice guidelines associated with regional differences in diabetes care? Herman WH, Kravitz B, Sun Y, the ADOPT Study Group Diabetologia (2003);46:suppl 2:A436 [Abstract] | |
| 16th International Diabetes Federation Congress, Paris (Poster) Prevalence and clinical significance of glutamic acid decarboxylase (GAD) antibodies in recently diagnosed type 2 diabetes in the ADOPT study cohort. Zinman B, Kahn SE, Haffner SM, Herman W, Heise MA, O'Neill MC, the ADOPT Study Group Diabetologia (2003);46:suppl 2:A148 [Abstract] | |
| 16th International Diabetes Federation Congress, Paris (Poster) Prevalence of microalbuminuria in recently diagnosed type 2 diabetes mellitus and its relationship to non-traditional risk factors: observations from the ADOPT study Viberti G, Freed MI, Holman R, Lachin J, Heise MA, the ADOPT Study Group Diabetologia (2003);46:suppl 2:A326 [Abstract] | |
| 16th International Diabetes Federation Congress, Paris (Poster) Lack of concordance of WHO and NCEP criteria for the diagnosis of the metabolic syndrome in recently diagnosed diabetes in North America and Europe in the ADOPT study cohort Kahn SE, Haffner SM, Zinman B, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group Diabetes Metabolism (2003);29:4S32 [Abstract] | |
| 16th International Diabetes Federation Congress, Paris (Poster) Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study Holman RR, Kahn SE, Heise MA, Porter LE, Freed MI, the ADOPT Study Group Diabetologia (2003);46:suppl 2:A198 [Abstract] | |
| 63rd Scientific Sessions of the American Diabetes Association, New Orleans (Poster) Ethnic differences in the prevalence of the metabolic syndrome in recently diagnosed type 2 diabetes in the North American cohort of the ADOPT study Haffner SM, Zinman B, Kahn SE, Herman WH, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group Diabetes (2003);52:suppl:A220 [Abstract] | |
| 63rd Scientific Sessions of the American Diabetes Association, New Orleans (Poster) Lack of concordance of NCEP and WHO criteria for the diagnosis of the metabolic syndrome in recently diagnosed diabetes in North America and Europe in the ADOPT study cohort Kahn SE, Haffner SM, Zinman B, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group Diabetes (2003);52:suppl:A222 [Abstract] | |
| 63rd Scientific Sessions of the American Diabetes Association, New Orleans (Poster) Prevalence of microalbuminuria and its relationship to non-traditional risk factors in recently diagnosed type 2 diabetes mellitus: observations from the ADOPT study Viberti G, Freed MI, Holman R, Lachin J, Heise MA, the ADOPT Study Group Diabetes (2003);52:suppl:A190 [Abstract] | |
| 63rd Scientific Sessions of the American Diabetes Association, New Orleans (Poster) Prevalence and clinical significance of glutamic acid decarboxylase (GAD) antibodies in recently diagnosed type 2 diabetes in the ADOPT study cohort Zinman B, Kahn SE, Haffner SM, Herman W, Heise MA, O'Neill MC, the ADOPT Study Group Diabetes (2003);52:suppl:A233 [Abstract] | |
| 63rd Scientific Sessions of the American Diabetes Association, New Orleans (Poster) The ADOPT study: symptoms and health status in a recently diagnosed type 2 diabetic population Herman W, Freed MI, Heise MA, Kravitz B, Perry A, the ADOPT Study Group Diabetes (2003);52:suppl:A263 [Abstract] | |
| 63rd Scientific Sessions of the American Diabetes Association, New Orleans (Poster) Risk of Heart Failure in Type 2 Diabetes Coleman R, Stevens RJ, Stratton IM, Adler A, Matthews D, Holman RR Diabetes (2003);52:Suppl 1:A217 | |
| 60th Scientific Sessions of the American Diabetes Association, Glasgow (Oral) Six-year results from the Early Diabetes Intervention Trial Holman RR, Blackwell L, Stratton IM, Manley SE, Tucker L, Frighi V Diabetic Medecine (2003);20:(Suppl 2):15 [Abstract] | |
| 2002 | 62nd Scientific Sessions of the American Diabetes Association, San Francisco (Poster) Forecasting Coronary Case Fatality in Type 2 Diabetes: A UKPDS Risk Engine Equation Stevens RJ, Coleman RL, Adler AI, Stratton IM, Holman RR Diabetes (2002);51:Suppl 2:A172 |
| 38th Annual Meeting of the European Association for the Study of Diabetes, Budapest (Poster) The Glycaemic Optimisation Outcomes in Diabetes (GOOD) feasibility study: glucose control and weight gain in a 1 year community-based study Potts NJ, Dudley CA, Holman RR Diabetologia (2002);45:Suppl 2:A243 [Abstract] | |
| 38th Annual Meeting of the European Association for the Study of Diabetes, Budapest (Poster) The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes Mohanlal N, Holman RR Diabetologia (2002);45:Suppl 2:A246 [Abstract] | |
| 38th Annual Meeting of the European Association for the Study of Diabetes, Budapest (Poster) The Glycaemic Optimisation Outcomes in Diabetes (GOOD) feasibility study: early use of combination therapies and insulin in general practice. Potts NJ, Dudley CA, Holman RR Diabetologia (2002);45:Suppl 2:A265 [Abstract] | |
| 2001 | 37th Annual Meeting of the European Association for the Study of Diabetes, Glasgow (Poster) Hypoglycaemia in patients with Type 2 diabetes in the UKPDS Cull CA, Wright AD, Macleod KM, Holman RR Diabetologia (2001);44:Suppl 1:A217 [Abstract] |
| 37th Annual Meeting of the European Association for the Study of Diabetes, Glasgow (Poster) Autoantibodies to IA2ic and to Phogrin increase the prediction for insulin requirement in patients with Type 2 Diabetes Bosi E, Locatelli M, Cull CA, Scirpoli M, Bonifacio E, Stratton IM, Holman RR, Bottazzo GF Diabetologia (2001);44:Suppl 1:A103 [Abstract] | |
| 37th Annual Meeting of the European Association for the Study of Diabetes, Glasgow (Poster) Altered postprandial responses in type 2 diabetes Mohanlal N, Holman RR Diabetologia (2001);44:Suppl 1:A165 [Abstract] | |
| 37th Annual Meeting of the European Association for the Study of Diabetes, Glasgow (Poster) Calcium/calmodulin dependent Protein Kinase II genes: genomic structure and screening for variants in subjects with type 2 diabetes Gloyn AL, Desai M, Clark A, Holman RR, Frayling TM, Hattersley AT, Ashcroft SJH Diabetologia (2001);44:Suppl 1:A88 [Abstract] | |
| 37th Annual Meeting of the European Association for the Study of Diabetes, Glasgow (Oral) Variation at the insulin VNTR locus but not the CTLA-4 locus is associated with age of onset and need for insulin therapy in latent autoimmune diabetes in adults (LADA) Horton VA, Stratton IM, Owen R, Holman RR, Levy JC, Clark A Diabetologia (2001);44:Suppl 1:A75 [Abstract] | |
| 2000 | 36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Oral) Sulphonylurea Therapy Over Six Years Does Not Delay Progression To Diabetes Herlihy OM, Morris RJ, Karunakaran S, Holman RR Diabetologia (2000);43:Suppl1:A73 [Abstract] |
| 36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Poster) Reinforced Healthy Living Advice Over Six Years Does Not Delay Progression To Diabetes Dyson PA, Mehta Z, Hammersley M, Holman RR Diabetologia (2000);43:Suppl1:A114 [Abstract] | |
| 36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Oral) Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS Cull CA, Wright AD, Holman RR Diabetologia (2000);43:Suppl 1:A40 [Abstract] | |
| 36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Oral) Butyrylcholinesterase K variant is associated with type 2 diabetes in UK caucasians Hashim Y, Shepherd D, Wiltshire S, Clarke A, Holman RR Diabetologia (2000);43:Suppl 1:A51 [Abstract] | |
| 36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Oral) Possible prevention of type 2 diabetes with acarbose or metformin over three years Citroën HA, Tunbridge FKE, Holman RR Diabetologia (2000);43:Suppl 1:A73 [Abstract] | |
| 36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Poster) ApoE ε2 and butyrylcholinesterase K variant are associated with coronary heart disease in type 2 diabetes Horton VA, Groves CJ, Naylor M, Owen R, Wiltshire S, Stratton IM, Green F, Holman RR Diabetologia (2000);43:Suppl 1:A86 [Abstract] | |
| 36th Annual Meeting of the European Association for the Study of Diabetes, Jerusalem (Poster) Standardised HbA1c measurements are essential for the management of glycaemia as a risk factor in diabetes Manley SE, Holman RR Diabetologia (2000);43:Suppl 1:A232 [Abstract] | |
| 60th Scientific Sessions of the American Diabetes Association, San Antonio (Poster) Possible Prevention of Type 2 Diabetes with Acarbose or Metformin Holman RR, North BV, Tunbridge FK Diabetes (2000);40:(Suppl 1):A111 [Abstract] | |
| 1998 | 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Oral) Diabetes in families study: The insulin resistance syndrome segregates into 5 underlying factors in non-diabetic siblings of type 2 diabetic patients. Morris RJ, Levy JC, Barrow BA, Ross IJ, Turner RC Diabetologia (1998);41:Suppl 1:A70 [Abstract] |
| 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster) Insulin VNTR and HLA DRB1/DQB1 loci affect age of presentation of autoimmune diabetes in adults Horton VA, Stratton IM, Owen RJ, Bennett ST, Todd JA, Holman RR, Turner RC Diabetologia (1998);41:Suppl 1:A105 [Abstract] | |
| 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster) Screening of SUR 1 and KIR6.2 promoters for mutations in different types of type 2 diabetes Gloyn AL, Hashim Y, Turner RC Diabetologia (1998);41:Suppl 1:A108 [Abstract] | |
| 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster) Hepatocyte nuclear factor-4α (MODY1) gene mutations in late-onset type 2 diabetics in the UK Shepherd DE, Hashim Y, Turner RC Diabetologia (1998);41:Suppl 1:A111 [Abstract] | |
| 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster) Paraoxonase polymorphism MET-LEU 54 is associated with fatal myocardial infarction in type 2 diabetic patients Groves CJ, Horton VA, Ritchie A, Owen RJ, Stratton IR, Green FR, Holman RR, Turner RC Diabetologia (1998);41:Suppl 1:A115 [Abstract] | |
| 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster) Elevated proinsulin but not amyloid polypeptide accompanies declining ß-cell function in type 2 diabetes McNamara CM, Clark A, Turner RC Diabetologia (1998);41:Suppl 1:A169 [Abstract] | |
| 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster) Hyperglycaemic siblings of type 2 diabetic patients have greater central obesity than their normoglycaemic siblings but similar physical activity indices. Herlihy OM, Barrow BA, Levy JC, Wareham NJ, Turner RC Diabetologia (1998);41:Suppl 1:A212 [Abstract] | |
| 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster) Retinopathy in subjects with increased fasting plasma glucose levels. Karunakaran S, Aldington S, North B, Ryder R, Holman RR Diabetologia (1998);41:Suppl 1:A283 [Abstract] | |
| 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster) Genetic predisposition to vascular complications of diabetes Izmajlowicz ML, Groves C, Horton V, Owen R, Stratton I, Turner RC, Green FR Diabetologia (1998);41:Suppl 1:A353 [Abstract] | |
| 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Oral) In normoglycaemic siblings of type 2 diabetic patients, obesity accounts for decreased insulin sensitivity but not for hypertension Levy JC, Morris RJ, Barrow BA, Ross IJ, Turner RC Diabetologia (1998);41:Suppl 1:A70 [Abstract] | |
| 34th Annual Meeting of the European Association for the Study of Diabetes, Barcelona (Poster) Hepatocyte nuclear factor 1-alpha (MODY 3) gene mutations in type 2 diabetics of different ethnicity Hashim Y, Shepherd DE, Li J, Chan J, Turner RC Diabetologia (1998);41:Suppl 1:A114 [Abstract] | |
| 1976 | Medical Research Society Meeting 1976, (Poster) A New Approach to the Treatment of Mild Diabetes Holman RR, Turner RC Clinical Science (1976);p18 [Abstract] |
| Medical Research Society Meeting 1976, (Poster) Beta Cell Deficiency in Maturity Onset Diabetes Turner RC, Holman RR, Hockaday TDR Clinical Science (1976);p18 [Abstract] | |
| 12th Annual Meeting of the European Association for the Study of Diabetes, Helsinki (Poster) A New Approach to the Treatment of Mild Diabetes Holman RR, Turner RC Diabetologia (1976);12:398-399 [Abstract] | |
OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ
Tel: +44 (0)1865 857242 Fax: +44 (0)1865 857241 Email: dtu@dtu.ox.ac.uk
Home | Freedom of Information | Privacy Policy | Copyright | Accessibility | OCDEM | NDM | Oxford University